Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease
2021/43/I/NZ7/00342
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
- NZ7_016: Inne zagadnienia pokrewne
- NZ5_003: Patogeneza chorób człowieka
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Jagielloński, Collegium Medicum
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 6
Call
OPUS 22 (LAP) – announced on 2021-09-15
- Amount awarded
- 1 224 272 PLN
- Project start date
- 2022-09-01
- Project end date
- 2027-09-22
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
p38α Mitogen-Activated Protein Kinase-An Emerging Drug Target for the Treatment of Alzheimer's Disease
- Authors:
- Detka J, Płachtij N, Strzelec M, Manik A, Sałat K
- Academic press:
- Molecules (year: 2024, volume: 29, pages: 4354), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/molecules29184354 – link to the publication